Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indocyanine Green Clearance Test in Liver Transplantation
NCT05228587Unknown
- Sponsor
- Policlinico Gemelli
- Start
- Feb 2022
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-blind, single-arm trial of indocyanine green in hepatic and hepatobiliary disorders, sponsored by Policlinico Gemelli. Primary endpoint: Indocyanine Green Plasma Disappearance Rate cut-off level for graft viability. Status: unknown.
02
Drugs
indocyanine green
03
Conditions
hepatic and hepatobiliary disorders
Beyond the preview
Go deeper on NCT05228587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05228587.